Familial flecked retinopathy

Summary

Familial flecked retinopathy (MONDO:0016420) is a disease (an umbrella term covering 5 Mondo subtypes). A subtype of hereditary macular dystrophy — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Umbrella term: 5 Mondo subtypes

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	familial flecked retinopathy
Mondo ID	MONDO:0016420
Orphanet	227786
ICD-11	979898273
Is cancer (heuristic)	no

Also known as: hereditary flecked retinopathy

Disease family

This is a subtype of hereditary macular dystrophy. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › retinal disorder › retinal degeneration › inherited retinal dystrophy › hereditary macular dystrophy › familial flecked retinopathy

Related subtypes (16): vitelliform macular dystrophy, cone dystrophy, coloboma of macula, coloboma of macula-brachydactyly type B syndrome, benign concentric annular macular dystrophy, macular dystrophy, fenestrated sheen type, macular coloboma-cleft palate-hallux valgus syndrome, macular corneal dystrophy, EEM syndrome, renal hypomagnesemia 5 with ocular involvement, macular dystrophy, X-linked, AICA-ribosiduria, occult macular dystrophy, patterned dystrophy of the retinal pigment epithelium, macular dystrophy, retinal, macular dystrophy with or without cone dysfunction

Subtypes (5): Doyne honeycomb retinal dystrophy, fundus albipunctatus, Bietti crystalline corneoretinal dystrophy, Kandori fleck retina, Stargardt disease

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.